Breaking News

CordenPharma Colorado Completes Highly Potent API Lab Expansion

Capable of handling highly potent compounds with an OEL as low as 1ng/m3.

By: Contract Pharma

Contract Pharma Staff

CordenPharma has completed a new highly potent active pharmaceutical ingredient (API) laboratory in its Boulder, CO, facility.   CordenPharma Colorado has extensive experience and capabilities in the development and manufacturing of highly potent APIs from clinical to commercial scale.   “Our new laboratory in Colorado is part of a development capacity expansion to address the strong market demand,” said Jason Bertola, director of CordenPharma’s global highly potent and oncology platform. “T...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters